Amgen (GB:0R0T)
UK Market

Amgen Stock Analysis & Ratings

GB:0R0T Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.00 - $0.00
Previous Close$244.68
Average Volume (3M)N/A
Market Cap$130.80B
P/E Ratio24.1
Next EarningsAug 02, 2022
Dividend Yield7.4 (3.04%)
Smart Score8
EPS (TTM)10.15



P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.



What was Amgen’s price range in the past 12 months?
Amgen lowest stock price was $0.00 and its highest was $0.00 in the past 12 months.
    What is Amgen’s market cap?
    Amgen’s market cap is $130.80B.
      What is Amgen’s price target?
      The average price target for Amgen is $240.00. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $295.00 ,the lowest forecast is $185.00. The average price target represents -1.98% Decrease from the current price of $244.85.
        What do analysts say about Amgen?
        Amgen’s analyst rating consensus is a ‘Hold. This is based on the ratings of 13 Wall Streets Analysts.
          When is Amgen’s upcoming earnings report date?
          Amgen’s upcoming earnings report date is Aug 02, 2022 which is in 76 days.
            How were Amgen’s earnings last quarter?
            Amgen released its earnings results on Apr 27, 2022. The company reported $4.25 earnings per share for the quarter, beating the consensus estimate of $4.095 by $0.155.
              Is Amgen overvalued?
              According to Wall Street analysts Amgen’s price is currently Overvalued.
                Does Amgen pay dividends?
                Amgen pays a Quarterly dividend of $1.94 which represents an annual dividend yield of 3.04%. Amgen’s last Quarterly dividend payment was on Jun 08, 2022. Amgen’s upcoming ex-dividend date is May 16, 2022
                  What is Amgen’s EPS estimate?
                  Amgen’s EPS estimate for its next earnings report is not yet available.
                  How many shares outstanding does Amgen have?
                  Amgen has 534,200,000 shares outstanding.
                    What happened to Amgen’s price movement after its last earnings report?
                    Amgen reported an EPS of $4.25 in its last earnings report, beating expectations of $4.095. Following the earnings report the stock price went down -5.361%.
                      Which hedge fund is a major shareholder of Amgen?
                      Among the largest hedge funds holding Amgen’s share is PRIMECAP Management Co. It holds Amgen’s shares valued at 4B.


                        Amgen Stock Analysis

                        Smart Score
                        Price Target
                        ▼(-1.98% Downside)
                        The Amgen stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                        Learn more about TipRanks Smart Score

                        Company Description


                        Founded in 1980, California-based Amgen, Inc. is one of the world's leading biotechnology companies, which is engaged in the discovery, development, manufacture and marketing of human therapeutics. It primarily focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology and neuroscience areas.

                        Similar Stocks
                        Price & Change
                        Johnson & Johnson
                        Merck & Company
                        Sanofi-Aventis Sa

                        Popular Stocks

                        What's Included in PREMIUM?
                        Make informed decisions based on Top Analysts' activity
                        Know what industry insiders are buying
                        Get actionable alerts from top Wall Street Analysts
                        Find out before anyone else which stock is going to shoot up
                        Get powerful stock screeners & detailed portfolio analysis